Erectile Dysfunction Drugs Market Growth 2013 - 2019

Transparency Market Research

Erectile Dysfunction Drugs Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019

Single User License: US $ 4795 Multi User License: US $ 7795 Corporate User License: US $ 10795

Buy Now Request Sample

Published Date: Oct 2013

98 Pages Report

REPORT DESCRIPTION Erectile Dysfunction Drugs Market is Expected to Reach USD 3.4 Billion Globally in 2019: Transparency Market Research Transparency Market Research is Published new Market Report "Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) -Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global erectile dysfunction drugs market was valued at USD 4.3 billion in 2012 and is expected to decline at a CAGR of (4.5%) from 2013 to 2019, to reach an estimated value of USD 3.4 billion in 2019. Erectile dysfunction is the inability to attain or maintain penile erection in men, sufficient for successful sexual intercourse. Erectile dysfunction is a common medical disorder primarily affecting men older than 40 years of age. In addition, other than the typical causes of erectile dysfunction, such as diabetes and hypertension, a number of common lifestyle related factors are also associated with development of the condition. These include obesity, excessive alcohol consumption, smoking, use of recreational drugs, and poor physical and psychological health. Commonly, oral drugs belonging to the PDE 5 inhibitors class form the

mainstay of erectile dysfunction treatment. Other treatment options include lifestyle modification, testosterone therapy, penile devices, injection therapies and psychotherapy. The global market for erectile dysfunction drugs has been studied from the perspective of currently marketed branded drugs and pipeline drugs. Branded drugs include Viagra (sildenafil citrate), Cialis (tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra...